Fractyl Health, Inc. (GUTS): Revenue

Annual figures by period end, from SEC filings.

Year ended 2025-12-31

2023-12-31 Revenue (USD) 2025-12-31

Period ended	Revenue	Change YoY	Source filing
2025-12-31	$0	-100.0%	2026-03-24, From 2025-01-01
2024-12-31	$93.0K	-22.5%	2026-03-24, From 2024-01-01
2023-12-31	$120.0K	n/a	2025-03-03, From 2023-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Revenue	Change YoY
Fractyl Health, Inc. (GUTS)	2025-12-31	$0	-100.0%
Baxter International Inc (BAX)	2025-12-31	$11.24B	+5.7%
Becton Dickinson & Co (BDX)	2025-09-30	$21.84B	+8.2%
3M Co (MMM)	2025-12-31	$24.95B	+1.5%
Teleflex Inc (TFX)	2025-12-31	$1.99B	+17.2%
West Pharmaceutical Services Inc (WST)	2025-12-31	$3.07B	+6.3%
Stryker Corp (SYK)	2025-12-31	$25.12B	+11.2%
Haemonetics Corp (HAE)	2026-03-28	$1.33B	-2.0%
KORU Medical Systems, Inc. (KRMD)	2025-12-31	$41.13M	+22.2%

Compare GUTS, BAX, BDX, MMM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗